Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells

Cancer Immunology, Immunotherapy

Volumn 56, Issue 3, 2007, Pages 391-396

  Na, Il Kang ^a   Keilholz, Ulrich ^a   Letsch, Anne ^a   Bauer, Sandra ^a   Asemissen, Anne Marie ^a   Nagorsen, Dirk ^a   Thiel, Eckhard ^a   Scheibenbogen, Carmen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CXCR3; GM CSF; T cells; Vaccination

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KEYHOLE LIMPET HEMOCYANIN; MONOPHENOL MONOOXYGENASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; VACMUN;

ADD ON THERAPY; ARTICLE; CANCER IMMUNIZATION; CELL MIGRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOMODULATION; MELANOMA; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; CANCER VACCINES; CELL LINE, TUMOR; COHORT STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMOCYANIN; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; MELANOMA; NEOPLASM STAGING; PEPTIDES; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 33845917387     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-006-0198-7     Document Type: Article

References (29)

1. Apodaca G, Aroeti B, Tang K, Mostov K (1993) Brefeldin-A inhibits the delivery of the polymeric immunoglobulin receptor to the basolateral surface of MDCK cells. J Biol Chem 268:20380-20385
2. Cole K, Strick C, Paradis T, Ogborne K, Loetscher M, Gladue R, Lin W, Boyd J, Moser B, Wood D, Sahagan B, Neote K (1998) Interferon-inducible T cell alpha chemoattractant (ITAC), a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187:2009-2021
3. Disis M, Bernhard H, Shiota F, Hand S, Gralow J, Huseby E, Gillis SMAC (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88:202-210
4. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan R (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543
5. Foley J, Yu C, Solow R, Yacobucci M, Peden K, Farber J (2005) Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes. J Immunol 174:4892-4900
6. Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ (2002) Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res 62:1462-1470
7. Hensbergen PJ, Wijnands PG, Schreurs MW, Scheper RJ, Willemze R, Tensen CP (2005) The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. J Immunother 28:343-351
8. Jinquan T, Quan S, Jacobi HH, Jing C, Millner A, Jensen B, Madsen HO, Ryder LP, Svejgaard A, Malling HJ, Skov PS, Poulsen LK (2000) CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood 96:1230-1238
9. Kim C, Rott L, Kunkel E, Genovese M, Andrew D, Wu L, Butcher E (2001) Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 108:1331-1339
10. Kim C, Nagata K, Butcher E (2003) Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation. J Immunol 171:152-158
11. Kunz M, Toksoy A, Goebeler M, Engelhardt E, Brocker E, Gillitzer R (1999) Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma. J Pathol 189:552-558
12. Letsch A, Keilholz U, Fluck M, Nagorsen D, Asemissen A, Schmittel A, Thiel E, Scheibenbogen C (2005) Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients. Int J Cancer 114:936-941
13. Liao F, Rabin R, Yannelli J, Koniaris L, Vanguri P, Farber J (1995) Human Mig chemokine, biochemical and functional characterization. J Exp Med 182:1301-1314
14. Mach N, Gillessen S, Wilson S, Sheehan C, Mihm M, Dranoff G (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or flt3-ligand. Cancer Res 60:3239-3246
15. Mullins I, Slingluff C, Lee J, Garbee C, Shu J, Anderson S, Mayer M, Knaus W, Mullins DW (2004) CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease. Cancer Res 64:7697-7701
16. Poluektova L, Moran T, Zelivyanskaya M, Swindells S, Gendelman H, Persidsky Y (2001) The regulation of alpha chemokines during HIV-1 infection and leukocyte activation: relevance for HIV-1-associated dementia. J Neuroimmunol 120:112-128
17. Qin S, Rottman J, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch A, Moser B, Mackay C (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-754
18. Rabin R, Alston M, Sircus J, Knollmann-Ritschel B, Moratz C, Ngo D, Farber J (2003) CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions. J Immunol 171:2812-2824
19. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A (1999) Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 29:2037-2045
20. Sauty A, Colvin R, Wagner L, Rochat S, Spertini F, Luster A (2001) CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J Immunol 167:7084-7093
21. Scheibenbogen C, Schadendorf D, Bechrakis N, Nagorsen D, Hofmann U, Servetopoulou F, Letsch A, Philipp A, Foerster M, Schmittel A, Thiel E, Keilholz U (2003) Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides. Int J Cancer 104:188-194
22. Skipper JC, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL Jr, Boon T, Hunt DF, Engelhard VH (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527-534
23. Slingluff CJ, Petroni G, Yamshchikov G, Barnd D, Eastham SGH, Patterson J, Deacon D, Hibbitts S, Teates D, Neese P, Grosh W, Chianese-Bullock K, Woodson E, Wiernasz CMP, Gibson J, Ross M, Engelhard V (2003) Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J Clin Oncol 21:4016-4026
24. Spitler LE, Grossbard ML, Ernstoff MS, Silver G, Jacobs M, Hayes FA, Soong SJ (2000) Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol 18:1614-1621
25. Suyama T, Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ichikawa T, Ueda T, Nikaido T, Ito H, Ishikura H (2005) Upregulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 103:258-267
26. Taub D, Lloyd A, Conlon K, Wang J, Ortaldo J, Harada A, Matsushima K, Kelvin D, Oppenheim J (1993) Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 177:1809-1814
27. Uehara S, Grinberg A, Farber J, Love P (2002) A role for CCR9 in T lymphocyte development and migration. J Immunol 168:2811-2819
28. Valmori D, Scheibenbogen C, Dutoit V, Nagorsen D, Asemissen A, Rubio-Godoy V, Rimoldi D, Guillaume P, Romero P, Schadendorf D, Lipp M, Dietrich P, Thiel E, Cerottini J, Lienard D, Keilholz U (2002) Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res 62:1743-1750
29. Wolfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Buschenfelde KH, Boon T (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24:759-764